The Irish Medicines Board (IMB) today released details of its key activities and performance highlights for 2013, a year in which the national regulatory authority played an active part in the introduction of interchangeable medicines in Ireland. In 2013, some 11 active substances were published by the IMB (representing over 580 medicines) and it is currently working through a further 29 priority substances.
The IMB’s review of 2013 also highlights a 20% increase in the numbers of counterfeit and illegal medicines detained by the IMB in co-operation with the Revenue’s Customs Service and An Garda Síochána. The IMB continues to emphasise the health dangers for those who purchase prescription medicines over the internet, as there are no guarantees as to the safety, quality or effectiveness of these products.
Download:
IMB Press Release
Further information:
Weber Shandwick PR - (01) 6760168
Orla Molloy- 087 770 5108